As of 2024-12-13, the Relative Valuation of Haemonetics Corp (HAE) is 86.61 USD. This relative valuation is based on P/E multiples. With the latest stock price at 82.30 USD, the upside of Haemonetics Corp based on Relative Valuation is 5.2%.
The range of the Relative Valuation is 76.18 - 101.21 USD.
| Range | Selected | |
| Trailing P/E multiples | 32.1x - 38.3x | 34.3x |
| Forward P/E multiples | 23.8x - 31.6x | 27.7x |
| Fair Price | 76.18 - 101.21 | 86.61 |
| Upside | -7.4% - 23.0% | 5.2% |
| Date | P/E |
| 2024-12-12 | 33.38 |
| 2024-12-11 | 33.80 |
| 2024-12-10 | 34.02 |
| 2024-12-09 | 33.64 |
| 2024-12-06 | 32.93 |
| 2024-12-05 | 32.72 |
| 2024-12-04 | 33.87 |
| 2024-12-03 | 34.58 |
| 2024-12-02 | 35.48 |
| 2024-11-29 | 35.48 |
| 2024-11-27 | 35.65 |
| 2024-11-26 | 35.91 |
| 2024-11-25 | 35.88 |
| 2024-11-22 | 34.70 |
| 2024-11-21 | 34.65 |
| 2024-11-20 | 34.44 |
| 2024-11-19 | 34.41 |
| 2024-11-18 | 35.76 |
| 2024-11-15 | 36.19 |
| 2024-11-14 | 36.81 |
| 2024-11-13 | 37.23 |
| 2024-11-12 | 37.88 |
| 2024-11-11 | 37.07 |
| 2024-11-08 | 35.46 |
| 2024-11-07 | 35.10 |
| 2024-11-06 | 31.70 |
| 2024-11-05 | 30.41 |
| 2024-11-04 | 29.82 |
| 2024-11-01 | 28.99 |
| 2024-10-31 | 28.86 |
| 2024-10-30 | 29.21 |
| 2024-10-29 | 29.65 |
| 2024-10-28 | 30.72 |
| 2024-10-25 | 30.65 |
| 2024-10-24 | 30.75 |
| 2024-10-23 | 29.73 |
| 2024-10-22 | 30.21 |
| 2024-10-21 | 30.37 |
| 2024-10-18 | 30.89 |
| 2024-10-17 | 30.80 |
| 2024-10-16 | 30.65 |
| 2024-10-15 | 30.50 |
| 2024-10-14 | 30.54 |
| 2024-10-11 | 30.41 |
| 2024-10-10 | 30.20 |
| 2024-10-09 | 30.87 |
| 2024-10-08 | 31.10 |
| 2024-10-07 | 31.31 |
| 2024-10-04 | 31.59 |
| 2024-10-03 | 31.67 |